Compare Cigna Corp (CI) vs Norwegian Cruise Line Holdings Ltd (NCLH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cigna Corp vs Norwegian Cruise Line Holdings Ltd — how do they compare? Cigna Corp trades at $272.72 (market cap $73.56B), while Norwegian Cruise Line Holdings Ltd trades at $18.69 (market cap $8.52B). The key difference: Cigna Corp is far larger — about 8.6× Norwegian Cruise Line Holdings Ltd's market cap, and Cigna Corp pays a 2.24% dividend while Norwegian Cruise Line Holdings Ltd pays none. Which is the better fit depends on your goals.
| CI | NCLH | |
|---|---|---|
Market Cap | $73.56B | $8.52B |
Sector | Health | Consumer Cyclical |
52-Week High | $311.00 | $26.94 |
52-Week Low | $244.41 | $14.79 |
Enterprise Value | $98.27B | $23.33B |
Dividend Yield | 2.24% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Cigna (CI) trades at $282.49, up 2.63% with strong earnings beats in recent quarters. The stock shows bearish technical signals but benefits from low valuation ratios like a P/E of 11.68 and P/S of 0.27. Recent Q2 2026 results exceeded expectations, with EPS of $7.78 beating estimates, and the company raised its full-year guidance to at least $30.45 adjusted EPS, reflecting robust growth in health services and insurance segments.
The outlook is positive due to consistent earnings outperformance and raised guidance, though technical weakness and competitive pressures pose risks. Analyst consensus is strongly bullish with a $338.90 price target, indicating ~20% upside potential from current levels, supported by dividend payments and institutional accumulation.
Norwegian Cruise Line Holdings (NCLH) trades at $19.25, down 0.62% on the day, with a bearish technical signal from moving averages. The company reported Q2 2026 EPS of $0.48, beating estimates, but faces headwinds from high fuel costs and reduced travel demand. Revenue grew to $9.83B in 2025, with a net income margin of 4.3%, while valuation ratios like P/E of 11.67 and P/S of 0.93 appear reasonable. Recent news highlights a turnaround plan focused on cost controls and fleet optimization.
The outlook for NCLH is mixed; analyst consensus is a Buy with a $20.73 price target, but risks include macroeconomic pressures and execution challenges. Upside potential exists if the turnaround plan succeeds, yet investors must weigh debt levels and volatile travel demand against valuation attractiveness.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Cigna Corp
Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM services were greatly expanded by its 2018 merger with Express Scripts and are mostly sold to health insurance plans and employers. Its largest PBM contract is the Department of Defense. In health insurance and other benefits, Cigna mostly serves employers through self-funding arrangements, but it also operates in government programs, such as Medicare Advantage. The company operates mostly in the U.S. with 15 million medical members covered as of the end of 2020, but its services extend internationally, covering another 2 million people.
Read more on CI →About Norwegian Cruise Line Holdings Ltd
Norwegian Cruise Line is the world's third-largest cruise company by berths (at more than 62,000), operating 29 ships across three brands (Norwegian, Oceania, and Regent Seven Seas), offering both freestyle and luxury cruising. The company has redeployed its entire fleet as of May 2022. With eight passenger vessels on order among its brands through 2027 (representing 20,000 incremental berths), Norwegian is increasing capacity faster than its peers, expanding its brand globally. Norwegian sailed to around 500 global destinations before the pandemic.
Read more on NCLH →
